Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (71)
Yang Liu, Li-Jun Kong, Na Li, Yun-He Liu, Mei-Qi Jia, Qiu-Ge Liu, Sai-Yang Zhang & Jian Song. (2023) Design, synthesis and biological evaluation of novel 2,4-diaminopyrimidine cinnamyl derivatives as inhibitors of FAK with potent anti-gastric cancer activities. Bioorganic Chemistry 141, pages 106895.
Crossref
Crossref
Yun-Qiong Gu, Kun Yang, Qi-Yuan Yang, Huan-Qing Li, Mei-Qi Hu, Meng-Xue Ma, Nan-Feng Chen, Yang-Han Liu, Hong Liang & Zhen-Feng Chen. (2023) Rhodium(III)–Picolinamide Complexes Act as Anticancer and Antimetastasis Agents via Inducing Apoptosis and Autophagy. Journal of Medicinal Chemistry 66:14, pages 9592-9606.
Crossref
Crossref
Mateusz Kciuk, Manzar Alam, Nemat Ali, Summya Rashid, Pola Głowacka, Rajamanikandan Sundaraj, Ismail Celik, Esam Bashir Yahya, Amit Dubey, Enfale Zerroug & Renata Kontek. (2023) Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications. Molecules 28:13, pages 5246.
Crossref
Crossref
Qionghui Pan, Qingyu Wang, Tianshu Zhao, Xinyu Zhao, Yixin Liang, Mengyun Shi, Cong Chen & Feng Lin. (2023) FAK inhibitor PF-562271 inhibits the migration and proliferation of high-grade serous ovarian cancer cells through FAK and FAK mediated cell cycle arrest. Medical Oncology 40:8.
Crossref
Crossref
Jingyu Zhang, Wei Li, Wenxin Wang, Qingqing Chen, Zishan Xu, Meijing Deng, Lin Zhou & Guoyang He. (2023) Dual roles of FAK in tumor angiogenesis: A review focused on pericyte FAK. European Journal of Pharmacology 947, pages 175694.
Crossref
Crossref
Yuanbo Jia, Jiahui Hu, Keli An, Qiang Zhao, Yang Dang, Hao Liu, Zhao Wei, Songmei Geng & Feng Xu. (2023) Hydrogel dressing integrating FAK inhibition and ROS scavenging for mechano-chemical treatment of atopic dermatitis. Nature Communications 14:1.
Crossref
Crossref
Brice A. P. Wilson, Ning Li, Juliana A. Martinez Fiesco, Masoumeh Dalilian, Dongdong Wang, Emily A. Smith, Antony Wamiru, Rohan Shah, Ekaterina I. Goncharova, John A. Beutler, Tanja Grkovic, Ping Zhang & Barry R. O’Keefe. (2023) Biochemical Discovery, Intracellular Evaluation, and Crystallographic Characterization of Synthetic and Natural Product Adenosine 3′,5′-Cyclic Monophosphate-Dependent Protein Kinase A (PKA) Inhibitors. ACS Pharmacology & Translational Science 6:4, pages 633-650.
Crossref
Crossref
Ning Ma, Erqian Xu, Qing Luo & Guanbin Song. (2023) Rac1: A Regulator of Cell Migration and a Potential Target for Cancer Therapy. Molecules 28:7, pages 2976.
Crossref
Crossref
Jinlin Zhang, Kangping Xu, Fei Yang, Yaoren Qiu, Jiayi Li, Jing Li, Wenxuan Wang, Guishan Tan, Zhenxing Zou & Fenghua Kang. (2023) Design, synthesis and evaluation of nitric oxide releasing derivatives of 2,4-diaminopyrimidine as novel FAK inhibitors for intervention of metastatic triple-negative breast cancer. European Journal of Medicinal Chemistry 250, pages 115192.
Crossref
Crossref
Tingting Chen, Juan Wang, Min Li, Qingqing Wu & Shuna Cui. (2023) Genistein Inhibits Proliferation and Metastasis in Human Cervical Cancer Cells through the Focal Adhesion Kinase Signaling Pathway: A Network Pharmacology-Based In Vitro Study in HeLa Cells. Molecules 28:4, pages 1919.
Crossref
Crossref
Jian Song, Xu Liu, Yi-Fan Zhang, Xin-Yi Tian, Meng-Yan Deng, Chen-Zheng Huang & Sai-Yang Zhang. (2023) The dual FAK-HDAC inhibitor MY-1259 displays potent activities in gastric cancers in vitro and in vivo. Bioorganic Chemistry 131, pages 106328.
Crossref
Crossref
Martin Schröder, Matthias Leiendecker, Ulrich Grädler, Juliane Braun, Andreas Blum, Marek Wanior, Benedict-Tilman Berger, Andreas Krämer, Susanne Müller, Christina Esdar, Stefan Knapp & Timo Heinrich. (2022) MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core. Journal of Medicinal Chemistry 66:1, pages 837-854.
Crossref
Crossref
Chunxiao Zhu, Xiaoqing Guan, Xinuo Zhang, Xin Luan, Zhengbo Song, Xiangdong Cheng, Weidong Zhang & Jiang-Jiang Qin. (2022) Targeting KRAS mutant cancers: from druggable therapy to drug resistance. Molecular Cancer 21:1.
Crossref
Crossref
Fei Wu, Yuanyuan Du, Xiujuan Hou & Wei Cheng. (2022) A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden. BMC Oral Health 22:1.
Crossref
Crossref
Xu Zheng, Xing Li, Liangliang Tian, Bin Wu, Jiawen Yu, Changyuan Wang, Xiuli Sun, Xiaodong Ma, Lixue Chen & Yanxia Li. (2022) Design, synthesis and activity evaluation of isopropylsulfonyl-substituted 2,4- diarylaminopyrimidine derivatives as FAK inhibitors for the potential treatment of pancreatic cancer. European Journal of Medicinal Chemistry 241, pages 114607.
Crossref
Crossref
Xinzeyu Yi, Zheng Wang, Xiang Hu & Aixi Yu. (2022) Affinity probes based on small-molecule inhibitors for tumor imaging. Frontiers in Oncology 12.
Crossref
Crossref
Cui Zhai, Nana Zhang, Jian Wang, Meng Cao, Jing Luan, Huan Liu, Qianqian zhang, Yanting Zhu, Yuxin Xue & Shaojun Li. (2022) Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation. Lung 200:5, pages 619-631.
Crossref
Crossref
Ana Carla Castro-Guijarro, Fiorella Vanderhoeven, Joselina Magali Mondaca, Analía Lourdes Redondo, Felipe Carlos Martin Zoppino, Juan Manuel Fernandez-Muñoz, Angel Matias Sanchez & Marina Inés Flamini. (2022) Combination Treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast Cancer Cell Metastasis. Cells 11:19, pages 2988.
Crossref
Crossref
Tongyue Zhang, Yijun Wang, Meng Xie, Xiaoyu Ji, Xiangyuan Luo, Xiaoping Chen, Bixiang Zhang, Danfei Liu, Yangyang Feng, Mengyu Sun, Wenjie Huang & Limin Xia. (2022) HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Yinan Zhao, Xuke Zhang, Ying Li, Yeling Li, Han Zhang, Ziteng Song, Jing Xu & Yuanqiang Guo. (2022) A natural xanthone suppresses lung cancer growth and metastasis by targeting STAT3 and FAK signaling pathways. Phytomedicine 102, pages 154118.
Crossref
Crossref
Tao Chen, Yan Liu, Jiang Liu, Minghai Tang, Hao Huang, Chunmei Bai, Wenting Si, Tao Yang, Xue Yuan, Yi Wen & Lijuan Chen. (2022) Design, synthesis and biological evaluation of novel FAK inhibitors with better selectivity over IR than TAE226. Bioorganic Chemistry 124, pages 105790.
Crossref
Crossref
Fei He, Lijun Yi & Changcheng Lai. (2022) Fut7 Promotes Adhesion and Invasion of Acute Lymphoblastic Leukemia Cells through the Integrin/Fak/Akt Pathway. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-9.
Crossref
Crossref
Ping Liu, Yinghui Sun, Shuang Liu, Jing Niu, Xijie Liu & Qiaoyun Chu. (2022) SY-707, an ALK/FAK/IGF1R inhibitor, suppresses growth and metastasis of breast cancer cells. Acta Biochimica et Biophysica Sinica 54:2, pages 252-260.
Crossref
Crossref
Mulu Geletu, Hanad Adan, Maximillian Niit, Rozanne Arulanandam, Esther Carefoot, Victoria Hoskin, Diana Sina, Bruce Elliott, Patrick Gunning & Leda Raptis. (2022) Modulation of Akt vs Stat3 activity by the focal adhesion kinase in non-neoplastic mouse fibroblasts. Experimental Cell Research 411:1, pages 112731.
Crossref
Crossref
Patricia A. Quispe, Martin J. Lavecchia & Ignacio E. León. (2022) Focal adhesion kinase inhibitors in the treatment of solid tumors: Preclinical and clinical evidence. Drug Discovery Today 27:2, pages 664-674.
Crossref
Crossref
Mohamed Jawed Ahsan. (2022) 1,3,4-Oxadiazole Containing Compounds As Therapeutic Targets For
Cancer Therapy. Mini-Reviews in Medicinal Chemistry 22:1, pages 164-197.
Crossref
Crossref
Eleni Michael, Savvas Polydorides & Georgios Archontis. 2022. Computational Peptide Science. Computational Peptide Science
383
402
.
T. Y. S. Le Large, M. F. Bijlsma, B. El Hassouni, G. Mantini, T. Lagerweij, A. A. Henneman, N. Funel, B. Kok, T. V. Pham, R. de Haas, L. Morelli, J. C. Knol, S. R. Piersma, G. Kazemier, H. W. M. van Laarhoven, E. Giovannetti & C. R. Jimenez. (2021) Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Tao Chen, Yan Liu, Mingsong Shi, Minghai Tang, Wenting Si, Xue Yuan, Yi Wen & Lijuan Chen. (2021) Design, synthesis, and biological evaluation of novel covalent inhibitors targeting focal adhesion kinase. Bioorganic & Medicinal Chemistry Letters 54, pages 128433.
Crossref
Crossref
Yueling Wu, Ning Li, Chengfeng Ye, Xingmei Jiang, Hui Luo, Baoyuan Zhang, Ying Zhang & Qingyu Zhang. (2021) Focal adhesion kinase inhibitors, a heavy punch to cancer. Discover Oncology 12:1.
Crossref
Crossref
Marcella Massimini, Mariarita Romanucci, Raffaella De Maria & Leonardo Della Salda. (2021) An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology. Frontiers in Veterinary Science 8.
Crossref
Crossref
Faika Başoğlu, Nuray Ulusoy‐Güzeldemirci, Gülşen Akalın‐Çiftçi, Serap Çetinkaya & Abdulilah Ece. (2021)
Novel imidazo[2,1‐
b
]thiazole‐based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation
. Chemical Biology & Drug Design 98:2, pages 270-282.
Crossref
Crossref
Boru Li, Shuangjian Qin, Ying Cai, Kai Zheng, Bingyu Wang, Runbing Li, Haiyan Huang, Ming Zeng, Fang Xiao & Xinyun Xu. (2021) Proteomic characteristics of PM2.5 -induced differentially expressed proteins in human renal tubular epithelial cells. Environmental Toxicology and Pharmacology 86, pages 103658.
Crossref
Crossref
Baoyuan Zhang, Yan Zhang, Jiangwei Zhang, Ping Liu, Bo Jiao, Zaiqi Wang & Ruibao Ren. (2021) Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling. Advanced Science 8:16, pages 2100250.
Crossref
Crossref
Mulu Geletu, Hanad Adan, Maximillian Niit, Rozanne Arulanandam, Esther Carefoot, Victoria Hoskin, Diana Sina, Bruce Elliott, Patrick Gunning & Leda Raptis. (2021) Modulation of Akt vs Stat3 activity by the focal adhesion kinase in non-neoplastic mouse fibroblasts. Experimental Cell Research 404:1, pages 112601.
Crossref
Crossref
Ting Li, Tianyi Ren, Chumei Huang, Yufang Li, Pengfei Yang, Gang Che, Lisi Luo, Yutong Chen, Siqi Peng, Yujing Lin & Linjuan Zeng. (2021) S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine. Biochemical Pharmacology 189, pages 114396.
Crossref
Crossref
Chiara Brullo & Bruno Tasso. (2021) New Insights on Fak and Fak Inhibitors. Current Medicinal Chemistry 28:17, pages 3318-3338.
Crossref
Crossref
Benedict-Tilman Berger, Marta Amaral, Daria B. Kokh, Ariane Nunes-Alves, Djordje Musil, Timo Heinrich, Martin Schröder, Rebecca Neil, Jing Wang, Iva Navratilova, Joerg Bomke, Jonathan M. Elkins, Susanne Müller, Matthias Frech, Rebecca C. Wade & Stefan Knapp. (2021) Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2. Cell Chemical Biology 28:5, pages 686-698.e7.
Crossref
Crossref
Yueheng Qi, Ye Li, Yu Fang, Hang Gao, Bingchao Qiang, Shuxia Wang & Huabei Zhang. (2021) Design, Synthesis, Biological Evaluation, and Molecular Docking of 2,4-Diaminopyrimidine Derivatives Targeting Focal Adhesion Kinase as Tumor Radiotracers. Molecular Pharmaceutics 18:4, pages 1634-1642.
Crossref
Crossref
Zhiliang Xu, Huazhu Li, Chenyang Lin, Binhua Zeng, Yulin Chen & Yanrong Luo. (2021) Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway. Journal of Bioenergetics and Biomembranes 53:2, pages 203-211.
Crossref
Crossref
Damiano Cosimo Rigiracciolo, Francesca Cirillo, Marianna Talia, Lucia Muglia, Jorge Silvio Gutkind, Marcello Maggiolini & Rosamaria Lappano. (2021) Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression. Cancers 13:4, pages 645.
Crossref
Crossref
Yordanos F.I. Setargew, Kaitlin Wyllie, Rhiannon D. Grant, Jessica L. Chitty & Thomas R. Cox. (2021) Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours. Cancers 13:3, pages 491.
Crossref
Crossref
Claudia Ollauri-Ibáñez & Itziar Astigarraga. (2021) Use of Antiangiogenic Therapies in Pediatric Solid Tumors. Cancers 13:2, pages 253.
Crossref
Crossref
Ioanna Antoniades, Maria Kyriakou, Anna Charalambous, Katerina Kalalidou, Andri Christodoulou, Maria Christoforou & Paris A. Skourides. (2021) FAK displacement from focal adhesions: a promising strategy to target processes implicated in cancer progression and metastasis. Cell Communication and Signaling 19:1.
Crossref
Crossref
Yumeng Zhang, Shu Liu, Shu Zhou, Dandan Yu, Junjie Gu, Qin Qin, Yu Cheng & Xinchen Sun. (2021) Focal adhesion kinase: Insight into its roles and therapeutic potential in oesophageal cancer. Cancer Letters 496, pages 93-103.
Crossref
Crossref
Eleni Michael, Savvas Polydorides, Vasilis J. Promponas, Paris Skourides & Georgios Archontis. (2020)
Recognition of
LD
motifs by the focal adhesion targeting domains of focal adhesion kinase and proline‐rich tyrosine kinase 2‐beta: Insights from molecular dynamics simulations
. Proteins: Structure, Function, and Bioinformatics 89:1, pages 29-52.
Crossref
Crossref
Baoping Xu, Chao Deng, Xue Wu, Ting Ji, Lin Zhao, Yuehu Han, Wenwen Yang, Yating Qi, Zheng Wang, Zhi Yang & Yang Yang. (2020) CCR9 and CCL25: A review of their roles in tumor promotion. Journal of Cellular Physiology 235:12, pages 9121-9132.
Crossref
Crossref
Janine Wörthmüller & Curzio Rüegg. (2020) The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication. International Journal of Molecular Sciences 21:23, pages 9107.
Crossref
Crossref
Bo Li, Yongliang Li, Céline Tomkiewicz-Raulet, Pascal Dao, Daniel Lietha, Expédite Yen-Pon, Zhiyun Du, Xavier Coumoul, Christiane Garbay, Mélanie Etheve-Quelquejeu & Huixiong Chen. (2020) Design, Synthesis, and Biological Evaluation of Covalent Inhibitors of Focal Adhesion Kinase (FAK) against Human Malignant Glioblastoma. Journal of Medicinal Chemistry 63:21, pages 12707-12724.
Crossref
Crossref
Clara Perrone, Silvia Pomella, Matteo Cassandri, Maria Rita Braghini, Michele Pezzella, Franco Locatelli & Rossella Rota. (2020) FAK Signaling in Rhabdomyosarcoma. International Journal of Molecular Sciences 21:22, pages 8422.
Crossref
Crossref
Danning Wang, Jinlan Gao, Chenyang Zhao, Sen Li, Di Zhang, Xiaoyu Hou, Xinbin Zhuang, Qi Liu & Yang Luo. (2020) Cyclin G2 Inhibits Oral Squamous Cell Carcinoma Growth and Metastasis by Binding to IGFBP3 and Regulating the FAK-SRC-STAT Signaling Pathway. Frontiers in Oncology 10.
Crossref
Crossref
Qiu-Yun Luo, Su-Na Zhou, Wen-Tao Pan, Jian Sun, Li-Qiong Yang, Lin Zhang, Miao-Zhen Qiu & Da-Jun Yang. (2020) A multi-kinase inhibitor APG-2449 enhances the antitumor effect of Ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition. Biochemical Pharmacology, pages 114318.
Crossref
Crossref
Iván Acebrón, Ricardo D Righetto, Christina Schoenherr, Svenja de Buhr, Pilar Redondo, Jayne Culley, Carlos F Rodríguez, Csaba Daday, Nikhil Biyani, Oscar Llorca, Adam Byron, Mohamed Chami, Frauke Gräter, Jasminka Boskovic, Margaret C Frame, Henning Stahlberg & Daniel Lietha. (2020) Structural basis of Focal Adhesion Kinase activation on lipid membranes. The EMBO Journal 39:19.
Crossref
Crossref
Tadatoshi Sato, Shiv Verma, Christian D. Castro Andrade, Maureen Omeara, Nia Campbell, Jialiang S. Wang, Murat Cetinbas, Audrey Lang, Brandon J. Ausk, Daniel J. Brooks, Ruslan I. Sadreyev, Henry M. Kronenberg, David Lagares, Yuhei Uda, Paola Divieti Pajevic, Mary L. Bouxsein, Ted S. Gross & Marc N. Wein. (2020) A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction. Nature Communications 11:1.
Crossref
Crossref
Ewa Toton, Izabela Kedziora, Aleksandra Romaniuk-Drapala, Natalia Konieczna, Mariusz Kaczmarek, Natalia Lisiak, Anna Paszel-Jaworska, Anna Rybska, Wiktoria Duszynska, Jaromir Budzianowski, Maria Rybczynska & Blazej Rubis. (2020) Effect of 3-O-acetylaleuritolic acid from in vitro-cultured Drosera spatulata on cancer cells survival and migration. Pharmacological Reports 72:1, pages 166-178.
Crossref
Crossref
Yang Jin, Li Lv, Shu-Xiang Ning, Ji-Hong Wang & Rong Xiao. (2020) The Anti-tumor Activity and Mechanisms of rLj-RGD3 on Human Laryngeal Squamous Carcinoma Hep2 Cells. Anti-Cancer Agents in Medicinal Chemistry 19:17, pages 2108-2119.
Crossref
Crossref
Pascaline Nguemgo Kouam, Helmut Bühler, Thomas Hero & Irenäus A. Adamietz. (2019) The increased adhesion of tumor cells to endothelial cells after irradiation can be reduced by FAK-inhibition. Radiation Oncology 14:1.
Crossref
Crossref
Yalu Liu, Xiaogan Wang, Lijuan Deng, Lingyan Ping, Yunfei Shi, Wen Zheng, Ningjing Lin, Xiaopei Wang, Meifeng Tu, Yan Xie, Weiping Liu, Zhitao Ying, Chen Zhang, Zhengying Pan, Xi Wang, Ning Ding, Yuqin Song & Jun Zhu. (2019) ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell International 19:1.
Crossref
Crossref
Yue Su, Ridong Li, Xianling Ning, Zhiqiang Lin, Xuyang Zhao, Juntuo Zhou, Jia Liu, Yan Jin & Yuxin Yin. (2019) Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities. European Journal of Medicinal Chemistry 177, pages 32-46.
Crossref
Crossref
Wayne A. Schroder, Thiago D. Hirata, Thuy T. Le, Joy Gardner, Glen M. Boyle, Jonathan Ellis, Eri Nakayama, Dilan Pathirana, Helder I. Nakaya & Andreas Suhrbier. (2019) SerpinB2 inhibits migration and promotes a resolution phase signature in large peritoneal macrophages. Scientific Reports 9:1.
Crossref
Crossref
Nicole S Bryce, Edna C Hardeman, Peter W Gunning & John G Lock. (2019) Chemical biology approaches targeting the actin cytoskeleton through phenotypic screening. Current Opinion in Chemical Biology 51, pages 40-47.
Crossref
Crossref
Chi Zhang, Simon R. Stockwell, May Elbanna, Robin Ketteler, Jamie Freeman, Bissan Al-Lazikani, Suzanne Eccles, Alexis De Haven Brandon, Florence Raynaud, Angela Hayes, Paul A. Clarke, Paul Workman & Sibylle Mittnacht. (2019) Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases. Oncogene 38:30, pages 5905-5920.
Crossref
Crossref
Tsung-Chuan Ho, Shu-I Yeh, Show-Li Chen & Yeou-Ping Tsao. (2019) The Psoriasis Therapeutic Potential of a Novel Short Laminin Peptide C16. International Journal of Molecular Sciences 20:13, pages 3144.
Crossref
Crossref
Ian L. Chin, Livia Hool & Yu Suk Choi. (2019) A Review of in vitro Platforms for Understanding Cardiomyocyte Mechanobiology. Frontiers in Bioengineering and Biotechnology 7.
Crossref
Crossref
FuiBoon Kai, Allison P. Drain & Valerie M. Weaver. (2019) The Extracellular Matrix Modulates the Metastatic Journey. Developmental Cell 49:3, pages 332-346.
Crossref
Crossref
Shyam More, Emilie Vomhof‑Dekrey & Marc Basson. (2019) ZINC4085554 inhibits cancer cell adhesion by interfering with the interaction of Akt1 and FAK. Oncology Letters.
Crossref
Crossref
Rachael Chang Lee & Hui K. Gan. (2019) BI 853520, a FAK-Simile of Prior FAK Inhibitors?. Targeted Oncology 14:1, pages 39-41.
Crossref
Crossref
Mei-Ren Pan, Ming-Feng Hou, Fu Ou-Yang, Chun-Chieh Wu, Shu-Jyuan Chang, Wen-Chun Hung, Hon-Kan Yip & Chi-Wen Luo. (2019) FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer. Journal of Clinical Medicine 8:1, pages 38.
Crossref
Crossref
Hermann AM Mucke. (2019) Patent Highlights August–September 2018. Pharmaceutical Patent Analyst 8:1, pages 7-14.
Crossref
Crossref
Mohamed A. Motaleb, Ismail T. Ibrahim, Mona O. Sarhan & Wafaa A. Zaghary. (2018)
Radioiodination and biological distribution of a new
s
-triazine derivative for tumor uptake evaluation
. Journal of Labelled Compounds and Radiopharmaceuticals 61:14, pages 1058-1068.
Crossref
Crossref
Rayan Naser, Abdullah Aldehaiman, Escarlet Díaz-Galicia & Stefan Arold. (2018) Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development. Cancers 10:6, pages 196.
Crossref
Crossref